0001363763-17-000003.txt : 20170120
0001363763-17-000003.hdr.sgml : 20170120
20170120211036
ACCESSION NUMBER: 0001363763-17-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170118
FILED AS OF DATE: 20170120
DATE AS OF CHANGE: 20170120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RespireRx Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0000849636
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330303583
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 126 VALLEY ROAD
STREET 2: SUITE C
CITY: GLEN ROCK
STATE: NJ
ZIP: 07452
BUSINESS PHONE: (201) 444-4947
MAIL ADDRESS:
STREET 1: 126 VALLEY ROAD
STREET 2: SUITE C
CITY: GLEN ROCK
STATE: NJ
ZIP: 07452
FORMER COMPANY:
FORMER CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEINGARTEN ROBERT N
CENTRAL INDEX KEY: 0001135337
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16467
FILM NUMBER: 17539716
MAIL ADDRESS:
STREET 1: 5439 LOCKHURST DRIVE
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-01-18
0
0000849636
RespireRx Pharmaceuticals Inc.
RSPI
0001135337
WEINGARTEN ROBERT N
C/O RESPIRERX PHARMACEUTICALS INC.
126 VALLEY ROAD, SUITE C
GLEN ROCK
NJ
07452
1
1
0
0
EVP & Chief Financial Officer
Common Stock Options (to purchase shares of Common Stock)
3.9
2017-01-18
4
A
0
50000
0
A
2022-01-18
Common Stock
50000
50000
D
Common Stock Options (to purchase shares of Common Stock)
7.3775
2021-03-31
Common Stock
73847
73847
D
Common Stock Options (to purchase shares of Common Stock)
6.396
2022-08-18
Common Stock
30770
30770
D
Common Stock Options (to purchase shares of Common Stock)
8.125
2022-06-30
Common Stock
46154
46154
D
Common Stock Options (to purchase shares of Common Stock)
16.25
2019-07-17
Common Stock
15385
15385
D
These Common Stock Options vest in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017.
The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested and exercisable.
These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested and exercisable.
These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested and exercisable.
These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.
/s/ Robert N. Weingarten
2017-01-20